Stocktoria
DiaMedica Therapeutics Inc. DMAC
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2008-01-04
DiaMedica Therapeutics Inc. financials (annual)
Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | $500,000 | — |
| R&D expense | $24.6M | $19.1M | $13.1M | $7.8M | $8.8M | $8.2M | $7.9M | $4.5M | $3.2M |
| Operating income | -$34.4M | -$26.7M | -$21.3M | -$14.0M | -$13.6M | -$12.7M | -$11.6M | -$6.8M | -$4.5M |
| Income tax | $28,000 | $30,000 | $43,000 | $28,000 | $28,000 | $27,000 | $31,000 | $80,000 | — |
| Net income | -$32.8M | -$24.4M | -$19.4M | -$13.7M | -$13.6M | -$12.3M | -$10.6M | -$5.7M | -$4.3M |
| Operating cash flow | -$29.1M | -$22.1M | -$18.7M | -$11.5M | -$12.3M | -$9.2M | -$9.1M | -$5.7M | -$3.9M |
| Free cash flow | -$29.1M | -$22.1M | -$18.8M | -$11.6M | -$12.3M | -$9.2M | -$9.1M | -$5.7M | -$3.9M |
| Cash & equivalents | $15.6M | $3.0M | $4.5M | $4.7M | $4.7M | $7.4M | $3.9M | $16.8M | $1.4M |
| Total assets | $61.4M | $46.3M | $54.2M | $34.4M | $45.6M | $28.1M | $9.1M | $18.3M | $1.8M |
| Shareholders' equity | $56.1M | $40.7M | $51.1M | $31.8M | $44.0M | $26.0M | $7.6M | $17.0M | $799,000 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.